Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

1,038 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    NPPA Revises The Ceiling Price Of Coronary Stent

    Drug price regulator NPPA has approved hike in prices of cardiac stents by 4.2 per cent in-line with the wholesale price index (WPI) of the previous calendar year, as per an official statement.
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    NPPA Sets Up PMRU In J&K To Track Drug Price Ceiling Violation

    NPPA has set up Price Monitoring and Resource Unit in Jammu & Kashmir Union Territory, taking the total number of PMRUs in the country to 12, to track drug price ceiling violation by pharma companies.
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
S&A Law Offices
  • Article

    Understanding The Food Safety And Standards (Alcoholic Beverages) First Amendment Regulations, 2025

    The Food Safety and Standards Authority of India (FSSAI) has recently issued the Food Safety and Standards (Alcoholic Beverages) First Amendment Regulations, 2025, aimed at updating and clarifying the standards...
    IndiaFood, Drugs, Healthcare, Life Sciences
    IndiaLaw LLP
    IndiaLaw LLP
  • Article

    WHO Pharma Highlights July 2019

    This segment of the newsletter is focused on sharing the recent regulatory reforms and updates on Healthcare and Pharmaceutical domain from the World Health Organization (WHO).
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    India's Tryst With "Evergreening" – An Ongoing Battle

    Evergreening is the term used for legal and technological alternatives adopted by Pharmaceutical companies to extend their exclusivity of over production and sale of patented medicines beyond the prescribed statutory timeline of 20 years.
    IndiaIntellectual Property
    S&A Law Offices
    S&A Law Offices
  • Article

    India's Tryst With "Evergreening" – An Ongoing Battle.

    Evergreening is the term used for legal and technological alternatives adopted by Pharmaceutical companies to extend their exclusivity of over production and sale of patented medicines beyond the prescribed statutory timeline of 20 years.
    IndiaIntellectual Property
    S&A Law Offices
    S&A Law Offices
  • Article

    Basmati Wars

    Basmati rice is exclusively grown in Indian sub-continent and India is the largest exporter of Basmati in the world.
    IndiaIntellectual Property
    R. K. Dewan & Co
    R. K. Dewan & Co
  • Article

    Bolar Exemption: Delhi High Court Upholds The Exploitation Of Patented Invention For Research And Development Purposes

    Once a patent is granted the patentee has complete rights over that particular invention in the jurisdiction the patent was granted.
    IndiaIntellectual Property
    InvnTree Intellectual Property Services Pvt. Ltd.
    InvnTree Intellectual Property Services Pvt. Ltd.
  • Article

    Compulsory License: Compromise Or Necessity

    Last year in July, Natco Pharma had filed application for CL in respect of Nexavar stating that the German company's drug was unaffordable for the average Indian.
    IndiaIntellectual Property
    S.S. Rana & Co.
    S.S. Rana & Co.
  • Article

    Compulsory License For Astrazeneca's Diabetes Management Drug Saxagliptin?

    In a recent development, a compulsory license (CL) application has been filed for the patent covering AstraZeneca's diabetes management drug Saxagliptin.
    IndiaIntellectual Property
    Khaitan & Co.
    Khaitan & Co.
  • Article

    Impact Of Proposed EU IPR Enforcement Mechanism On The Growth Of Indian Generic Drugs

    India is one of the largest suppliers of low cost generic medicines in the world.
    IndiaIntellectual Property
    S.S. Rana & Co.
    S.S. Rana & Co.
  • Article

    Merck Enters Into Licensing Deal With Five Indian Companies For Supply Of Oral Covid-19 Drug

    Recently, Merck, also known as MSD, has entered into licensing agreements with five Indian generics drug manufacturers to manufacture and supply oral Covid-19 drug Molnupiravir.
    IndiaIntellectual Property
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
  • Article

    Molecule Landscape Search: A Useful Approach To Drug Discovery

    The drug discovery and development in the pharma sector is progressing beyond the traditional synthesis of Active Pharmaceutical Ingredient/pharmaceuticals to save time and cost.
    IndiaIntellectual Property
    Accures Legal
    Accures Legal
  • Article

    Patents In Pharmaceutical Industry

    A patent is a type of intellectual property right that provides protection over any novel invention and also, gives the exclusive right to sell, use, create and/or manufacture the patented product.
    IndiaIntellectual Property
    S&A Law Offices
    S&A Law Offices
  • Article

    Sun Pharma And Celegene Settle Patent Dispute Over Lenalidomide (Revlimid®)

    On the other hand, all Hatch-Waxman litigation between Sun Pharma and Celgene, regarding the Revlimid patents will be dismissed.
    IndiaIntellectual Property
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
  • Article

    The GI Tag List Additions!

    In our article – ‘Does Your Product Have a Location?1' dated August 13, 2018, we discussed Geographical Indications and their application in India. We bring to you a recent update on the same.
    IndiaIntellectual Property
    R. K. Dewan & Co
    R. K. Dewan & Co
  • Article

    Food Safety Auditing With Great Care

    The rapidly growing economy of India has seen a massive development in various arenas of the commercial sector.
    IndiaFood, Drugs, Healthcare, Life Sciences
    S.S. Rana & Co.
    S.S. Rana & Co.
  • Article

    FSSAI License No. Mandatory On Receipts By Restaurants- From October 01, 2021

    The Food Safety and Standards Authority of India vide its notification dated June 8, 2021, has directed the food businesses in India to mention FSSAI license/registration number on receipts/invoices/cash memos/bills etc. ...
    IndiaFood, Drugs, Healthcare, Life Sciences
    S.S. Rana & Co.
    S.S. Rana & Co.
  • Article

    IAVI And SII Collaborate To Develop Affordable And Accessible Antibody Products For HIV Globally

    Serum Institute of India was founded to address the shortage of life-saving vaccines in India.
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    BREXIT: European Medicines Agency (EMA) To Relocate To Amsterdam, The Netherlands

    On November 20, 2017, the European Medicines Agency (EMA) announced that it will relocate to Amsterdam in the Netherlands.
    European UnionFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Showing 161–180 of 1038 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics